c-myc mRNA expression and genomic alterations in mantle cell lymphomas and other nodal non-Hodgkin's lymphomas

Leukemia

Volumn 13, Issue 12, 1999, Pages 2087-2093

  Hernandez L ^a   Hernandez S ^a   Bea S ^a   Pinyol, M ^a   Ferrer, A ^b   Bosch, F ^b   Nadal, A ^c   Fernandez P L ^a   Palacin A ^a   Montserrat, E ^b   Campo, E ^a,d  

^a Laboratory of Anatomic Pathology   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c Hospital Casa de Maternitat   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

Author keywords

c myc; Mantle cell lymphoma; Overexpression

Indexed keywords

CYCLIN D1; MESSENGER RNA;

ARTICLE; B CELL LYMPHOMA; CLINICAL ARTICLE; EXON; GENE ACTIVATION; GENE AMPLIFICATION; GENE MUTATION; HUMAN; HUMAN TISSUE; INTRON; MANTLE CELL LYMPHOMA; NONHODGKIN LYMPHOMA; ONCOGENE C MYC; PRIORITY JOURNAL;

EID: 0345440051     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401599     Document Type: Article

References (40)

1. Rosenberg CL, Wong E, Petty EM, Bale AE, Tsujimoto Y, Harris NL, Arnold A. PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. Proc Natl Acad Sci USA 1991; 88: 9638-9642.
2. Bosch F, Jares P, Campo E, Lopez-Guillermo A, Piris MA, Villamor N, Tassies D, Jaffe ES, Montserrat E, Rozman C, Cardesa A. PRAD1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Blood 1994; 84: 2726-2732.
3. Sherr CJ. G1 phase progression: cycling on cue. Cell 1994; 79: 551-555.
4. Xiao ZX, Ginsberg D, Ewen M, Livingston DM. Regulation of the retinoblastoma protein-related protein p107 by G1 cyclin-associated kinases. Proc Natl Acad Sci USA 1996; 93: 4633-4637.
5. Lovec H, Grzeschiczek A, Kowalski MB, Moroy T. Cyclin D1/bcl1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. EMBO J 1994; 13: 3487-3495.
6. Lovec H, Sewing A, Lucibello FC, Muller R, Moroy T. Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation. Oncogene 1994; 9: 323-326.
7. Bodrug SE, Warner BJ, Bath ML, Lindeman GJ, Harris AW, Adams JM. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J 1994; 13: 2124-2130.
8. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schimdt EV. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 1994; 369: 669-671.
9. Marcu KB, Bossone SA, Patel AJ. Myc function and regulation. Annu Rev Biochem 1992; 61: 809-860.
10. Spencer CA, Groudine M. Control of c-myc regulation in normal and neoplastic cells. Adv Cancer Res 1991; 68: 1-48.
11. Yu BW, Ichinose I, Bonham MA, Zajac-Kaye M. Somatic mutations in c-myc intron I cluster in discrete domains that define protein binding sequences. J Biol Chem 1993; 268: 19586-19592.
12. Hoang AT, Lutterbach B, Lewis BC, Yano T, Chou TY, Barrett JF, Raffeld M, Hann SR, Dang CV. A link between increased transforming activity of lymphoma-derived myc mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-myc transactivation domain. Mol Cell Biol 1995; 15: 4031-4042.
13. Yano T, Sander CA, Clark HM, Dolezal MV, Jaffe ES, Raffeld M. Clustered mutations in the second exon of the myc gene in sporadic Burkitt's lymphoma. Oncogene 1993; 8: 2741-2748.
14. Brennscheidt U, Eick D, Kunzmann R, Martens U, Kiehntopf M, Mertelsmann R, Herrmann F. Burkitt-like mutations in the c-myc gene locus in prolymphocytic leukemia. Leukemia 1994; 8: 897-902.
15. Inghirami G, Macri L, Cesarman E, Chadburn A, Zhong J, Knowles DM. Molecular characterization of CD30+ anaplastic large-cell lymphoma: high frequency of c-myc proto-oncogene activation. Blood 1994; 83: 3581-3590.
16. Clark HM, Yano T, Otsuki T, Jaffe ES, Shibata D, Raffeld M. Mutations in the coding region of c-myc in AIDS-associated and other aggressive lymphomas. Cancer Res 1994; 54: 3383-3386.
17. Peng H, Diss T, Isaacson PG, Pan L. c-myc gene abnormalities in mucosa-associated lymphoid tissue (MALT) lymphomas. J Pathol 1997; 181: 381-386.
18. Campo E, Raffeld M, Jaffe ES. Mantle cell lymphoma. Semin Hematol 1999; 36: 115-127.
19. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson P, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri S, Piris MA, Ralfkiaer E, Warnke RA. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-1392.
20. Glisin V, Crkvenjakov R, Byus C. Ribonucleic acid isolated by cesium chloride centrifugation. Biochemistry 1974; 13: 2633-2637.
21. Hernández S, Hernández L, Beà S, Cazorla M, Fernández PL, Nadal A, Muntané J, Mallofré C, Montserrat E, Cardesa A, Campo E. Cdc25 cell cycle activating phosphatases and c-myc expression in human non-Hodgkin's lymphomas. Cancer Res 1998; 58: 1762-1767.
22. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 1989; 86: 2766-2770.
23. Jares P, Fernández PL, Nadal A, Cazorla M, Hernández L, Pinyol M, Hernández S, Traserra J, Cardesa A, Campo E. p16MTS1/cdk41 mutations and concomitant loss of heterozygosity at 9p21-23 are frequent events in squamous cell carcinoma of the larynx. Oncogene 1997; 15: 1445-1453.
24. Cattoretti G, Becker MH, Key G, Duchrow M, Schluter C, Galle J, Gerdes J. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB-1 and MIB-3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992; 168: 357-363.
25. Kaplan GL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 547-581.
26. Peto R, Pike MC. Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data. Biometrics 1973; 29: 579-584.
27. Jares P, Campo E, Pinyol M, Bosch F, Miquel R, Fernandez PL, Sanchez-Beato M, Soler F, Perez-Losada A, Nayach I, Mallofre C, Piris MA, Montserrat E, Cardesa A. Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity. Am J Pathol 1996; 148: 1591-1600.
28. Rothberg PG, Otto YM. A polymorphic variant of human c-myc: asnl 1-ser. Mamm Genome 1995; 6: 209-211.
29. Steiner P, Philipp A, Lukas J, Godden-Kent D, Pagano M, Mittnacht S, Bartek J, Eilers M. Identification of a myc-dependent step during the formation of active G1 cyclin-cdk complexes. EMBO J 1995; 14: 4814-4826.
30. Galaktionov K, Chen X, Beach D. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 1996; 382: 511-517.
31. Fellbaum C, Radaszkiewicz T, Ruhri C, Putz B, Lehmacher W, Hofler H. C-myc mRNA expression in non-Hodgkin's lymphomas. Virchows Arch B Cell Pathol Incl Mol Pathol 1992; 62: 61-68.
32. Cesarman E, Dalla Favera R, Bentley D, Groudine M. Mutations in the first exon are associated with altered transcription of c-myc in Burkitt lymphoma. Science 1987; 238: 1272-1275.
33. Kerppola TK, Kane CM. Intrinsic sites of transcription termination and pausing in the c-myc gene. Mol Cell Biol 1988; 8: 4389-4394.
34. Zajac-Kaye M, Levens D. Phosphorylation-dependent binding of a 138-kDa myc intron factor to a regulatory element in the first intron of the c-myc gene. J Biol Chem 1990; 265: 4547-4551.
35. 2-terminal domain of c-myc increases transactivation of gene expression. J Biol Chem 1991; 266: 23521-23524.
36. Rechavi G, Katzir N, Brok Simoni F, Holtzman F, Mandel M, Gurfinkel N, Givol D, Ben Bassat I, Ramot B. A search for bcl1, bcl2, and c-myc oncogene rearrangements in chronic lymphocytic leukemia. Leukemia 1989; 3: 57-60.
37. Yano T, Jaffe ES, Longo DL, Raffeld M. MYC rearrangements in histologically progressed follicular lymphomas. Blood 1992; 80: 758-767.
38. INK4A as upstreams regulators of Myc. Oncogene 1997; 15: 179-192.
39. Pinyol M, Cobo F, Bea S, Jares P, Nayach I, Fernandez PL, Montserrat E, Cardesa A, Campo E. p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas. Blood 1998; 91: 2977-2984.
40. Dreyling MH, Bullinger L, Ott G, Stilgenbauer S, Muller-Hermelink HK, Bentz M, Hiddemann W, Dohner H. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma. Cancer Res 1997; 57: 4608-4614.